AllianceBernstein’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-39,200
| Closed | -$45.1K | – | 3273 |
|
2025
Q1 | $45.1K | Hold |
39,200
| – | – | ﹤0.01% | 3142 |
|
2024
Q4 | $240K | Sell |
39,200
-2,030
| -5% | -$12.4K | ﹤0.01% | 2978 |
|
2024
Q3 | $682K | Hold |
41,230
| – | – | ﹤0.01% | 2504 |
|
2024
Q2 | $283K | Buy |
41,230
+8,930
| +28% | +$61.3K | ﹤0.01% | 2934 |
|
2024
Q1 | $312K | Hold |
32,300
| – | – | ﹤0.01% | 2784 |
|
2023
Q4 | $268K | Sell |
32,300
-3,060
| -9% | -$25.4K | ﹤0.01% | 2890 |
|
2023
Q3 | $295K | Buy |
35,360
+2,590
| +8% | +$21.6K | ﹤0.01% | 2810 |
|
2023
Q2 | $302K | Buy |
32,770
+6,870
| +27% | +$63.4K | ﹤0.01% | 2857 |
|
2023
Q1 | $356K | Hold |
25,900
| – | – | ﹤0.01% | 2708 |
|
2022
Q4 | $441K | Buy |
25,900
+1,604
| +7% | +$27.3K | ﹤0.01% | 2694 |
|
2022
Q3 | $552K | Sell |
24,296
-604
| -2% | -$13.7K | ﹤0.01% | 2597 |
|
2022
Q2 | $449K | Buy |
24,900
+9,900
| +66% | +$179K | ﹤0.01% | 2716 |
|
2022
Q1 | $401K | Hold |
15,000
| – | – | ﹤0.01% | 2756 |
|
2021
Q4 | $440K | Hold |
15,000
| – | – | ﹤0.01% | 2788 |
|
2021
Q3 | $986K | Sell |
15,000
-500
| -3% | -$32.9K | ﹤0.01% | 2489 |
|
2021
Q2 | $1.29M | Buy |
15,500
+3,500
| +29% | +$291K | ﹤0.01% | 2411 |
|
2021
Q1 | $920K | Sell |
12,000
-1,000
| -8% | -$76.7K | ﹤0.01% | 2433 |
|
2020
Q4 | $1.15M | Sell |
13,000
-100
| -0.8% | -$8.83K | ﹤0.01% | 2226 |
|
2020
Q3 | $967K | Buy |
13,100
+2,100
| +19% | +$155K | ﹤0.01% | 2196 |
|
2020
Q2 | $803K | Buy |
11,000
+2,700
| +33% | +$197K | ﹤0.01% | 2301 |
|
2020
Q1 | $466K | Buy |
+8,300
| New | +$466K | ﹤0.01% | 2383 |
|